Medical research has shortchanged women for decades. This is particularly true of older women, leaving physicians without critically important information about how to best manage their health.
Pfizer plans to pull out of BIO, following moves by other large drugmakers to reduce lobbying footprint
Pfizer is planning to leave the Biotechnology Innovation Organization, a source familiar with the matter confirmed to Endpoints News, as it will not renew its